Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MODD logo MODD
Upturn stock ratingUpturn stock rating
MODD logo

Modular Medical Inc (MODD)

Upturn stock ratingUpturn stock rating
$0.73
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/17/2025: MODD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $8

1 Year Target Price $8

Analysts Price Target For last 52 week
$8 Target price
52w Low $0.63
Current$0.73
52w High $2.5

Analysis of Past Performance

Type Stock
Historic Profit -51.28%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/17/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 38.67M USD
Price to earnings Ratio -
1Y Target Price 8
Price to earnings Ratio -
1Y Target Price 8
Volume (30-day avg) 1
Beta -4.99
52 Weeks Range 0.63 - 2.50
Updated Date 09/17/2025
52 Weeks Range 0.63 - 2.50
Updated Date 09/17/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.51

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -111.54%
Return on Equity (TTM) -215.41%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 34521815
Price to Sales(TTM) -
Enterprise Value 34521815
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -3.21
Shares Outstanding 55274600
Shares Floating 44309774
Shares Outstanding 55274600
Shares Floating 44309774
Percent Insiders 5.76
Percent Institutions 38.87

ai summary icon Upturn AI SWOT

Modular Medical Inc

stock logo

Company Overview

overview logo History and Background

Modular Medical, Inc. is a medical device company focused on the development and commercialization of easy-to-use and affordable diabetes technology. Founded to address the limitations of existing continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, the company aims to create accessible and user-friendly solutions for managing diabetes.

business area logo Core Business Areas

  • Insulin Delivery Systems: Development of a novel, modular insulin pump designed for ease of use and affordability.
  • Continuous Glucose Monitoring (CGM) Integration: Integration of the insulin pump with CGM devices for closed-loop automated insulin delivery.

leadership logo Leadership and Structure

Details on the specific leadership team and organizational structure are generally available on their investor relations website or company profile pages. Specific names and titles would need to be pulled directly from those sources.

Top Products and Market Share

overview logo Key Offerings

  • Insulin Pump (Under Development): Modular Medical is developing a novel insulin pump designed for affordability and ease of use. As the pump is still under development, it does not currently have market share or revenue. Competitors include Medtronic (MDT), Insulet (PODD), and Tandem Diabetes Care (TNDM).

Market Dynamics

industry overview logo Industry Overview

The diabetes management market is experiencing significant growth, driven by the increasing prevalence of diabetes and advancements in technology such as CGM and automated insulin delivery systems. Key trends include miniaturization of devices, enhanced connectivity, and improved user interfaces.

Positioning

Modular Medical aims to disrupt the diabetes management market by offering a more affordable and user-friendly insulin pump solution. They are positioning themselves as a value-driven alternative to established players.

Total Addressable Market (TAM)

The global diabetes care devices market is estimated to be in the billions of USD. Modular Medical's TAM is tied to the portion of that market served by insulin pumps. Their positioning aims to increase market penetration among price-sensitive patients.

Upturn SWOT Analysis

Strengths

  • Innovative product design (modular, user-friendly)
  • Focus on affordability
  • Potential for disruption in the insulin pump market
  • Experienced management team (Requires verification of this information)

Weaknesses

  • Product still under development
  • Limited funding and resources compared to established players
  • No current revenue stream
  • Dependence on regulatory approvals

Opportunities

  • Growing demand for diabetes management solutions
  • Increasing adoption of CGM and automated insulin delivery systems
  • Partnerships with diabetes clinics and healthcare providers
  • Expansion into international markets

Threats

  • Competition from established players with significant resources
  • Regulatory hurdles and approval delays
  • Technological advancements by competitors
  • Reimbursement challenges from insurance providers

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Insulet (PODD)
  • Tandem Diabetes Care (TNDM)

Competitive Landscape

Modular Medical aims to compete on price and ease of use. Established players have significant resources and market share, but Modular Medical's innovative design could attract price-sensitive customers.

Growth Trajectory and Initiatives

Historical Growth: No historical revenue growth due to the pre-revenue stage of the company.

Future Projections: Future growth is contingent on successful product launch and market penetration. Analyst estimates (if available) would be highly speculative at this stage.

Recent Initiatives: Recent initiatives likely include ongoing product development, clinical trials, and seeking regulatory approvals.

Summary

Modular Medical is an early-stage medical device company with the potential to disrupt the diabetes management market with its affordable and user-friendly insulin pump. The company faces significant challenges, including competition from established players, regulatory hurdles, and the need to secure additional funding. Their innovative design and focus on affordability could be a key differentiator. Securing FDA approval will be a critical milestone for future growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Industry Reports
  • Analyst Reports (where available)

Disclaimers:

This analysis is based on publicly available information and represents an opinion. Investment decisions should be made after consulting with a qualified financial advisor. Market share data is estimated and may vary.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Modular Medical Inc

Exchange NASDAQ
Headquaters San Diego, CA, United States
IPO Launch date 2007-01-25
CEO -
Sector Healthcare
Industry Medical Devices
Full time employees 53
Full time employees 53

Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California.